Navigation Links
Landmark Research Study is Launched to Assess Impact of Personal Genetic Testing
Date:10/9/2008

l of improving health outcomes in individuals across the population. Navigenics educates and empowers customers with knowledge of their genetic predispositions, and then motivates them to act on the information to prevent the onset of disease, achieve earlier diagnosis, appropriately manage disease, or otherwise lessen its impact. Navigenics' lead investors are Kleiner Perkins Caufield and Byers, Sequoia Capital and MDV-Mohr Davidow Ventures. More information can be found at http://www.navigenics.com.

ABOUT AFFYMETRIX

Affymetrix GeneChip(R) microarray technology is the industry-standard tool for analyzing complex genetic information. After inventing microarray technology in the late 1980s, Affymetrix scientists have been dedicated to developing innovative products that provide researchers with a more complete view of the genome. These products continue to accelerate genetic research and enable scientists to develop diagnostics and tailor treatments for individual patients by identifying and measuring the genetic information associated with complex diseases. Headquartered in Santa Clara, Calif., Affymetrix has about 1,100 employees worldwide and has manufacturing facilities in Sacramento, Calif., Cleveland, Ohio, and Singapore and maintains sales and distribution operations across Europe and Asia. More information about Affymetrix can be found at http://www.affymetrix.com.

ABOUT MICROSOFT

Microsoft is committed to improving health around the world through software innovation. Over the past 12 years Microsoft has steadily increased its investments in health, with a focus on addressing the challenges of health providers, health and social services organizations, payers, consumers and life sciences companies, worldwide. Microsoft closely collaborates with a broad ecosystem of partners and develops its own powerful health solutions, such
'/>"/>

SOURCE Scripps Translational Science Institute
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Landmark COPD Trial UPLIFT(R) Shows SPIRIVA(R) HandiHaler(R) Sustained Lung Function Improvements Over Four Years
2. Established Safety Profile of Spiriva Confirmed by 30 Rigorously Controlled Clinical Trials and the Landmark Trial UPLIFT
3. Landmark HIV/AIDS Publication Launches at International AIDS Society Conference in Mexico City
4. Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation
5. TYKERB(R) (Lapatinib) to be Investigated in Landmark Early Breast Cancer Trial
6. Landmark ONTARGET(TM) Trial Demonstrates Micardis(R) is Equally Effective as Ramipril, with Fewer Discontinuations, in a Broad High-Risk Cardiovascular Population
7. JACC Identifies DEFER with 5-year Outcomes as Landmark Trial
8. Hospital Launches Landmark Emergency Medicine Project
9. Long-Term Data from a Landmark Phase III Trial Show Survival Benefit at Three- and Four-Years in Patients with Glioblastoma multiforme
10. Viatronix V3D-Colon Utilized in Another Landmark Study
11. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)..., , JOHANNESBURG, South Africa, Nov. 2...uth Africa Company of the Year Award in the Generi...ro South Africa Limited. ,, (Logo: http://www....or the Company of the Year Award, the following cr...rmance against key competitors: growth strategy an...
(Date:11/25/2009)..., , PRINCETON, N.J., Nov. 25 /PRNewswire-... clinical stage pharmaceutical company committed t...l drugs to treat viral infections, reported financ..., 2009. At September 30, 2009 Pharmasset held $58.... investments. ,, Pipeline Update and 2009 Hig...
(Date:11/25/2009)..., , WEST PALM BEACH, Fla., Nov. 25 /PRNe...earing impaired Americans, especially the 27 milli...ays may not be all that happy, says audiologist Ci...of HearUSA (Amex: EAR ), one of America,s largest...tudies have linked hearing loss to stress, frustra...
Breaking Medicine Technology:Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 2Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 3Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 4Pharmasset Reports Fiscal Year End 2009 Financial Results 2Pharmasset Reports Fiscal Year End 2009 Financial Results 3Pharmasset Reports Fiscal Year End 2009 Financial Results 4Pharmasset Reports Fiscal Year End 2009 Financial Results 5Pharmasset Reports Fiscal Year End 2009 Financial Results 6Pharmasset Reports Fiscal Year End 2009 Financial Results 7Pharmasset Reports Fiscal Year End 2009 Financial Results 8Pharmasset Reports Fiscal Year End 2009 Financial Results 9Pharmasset Reports Fiscal Year End 2009 Financial Results 10For Millions With Untreated Hearing Loss, Holiday Season Can be Especially Difficult 2For Millions With Untreated Hearing Loss, Holiday Season Can be Especially Difficult 3Lumie Reveals Light Levels Received In July Are As Low As A Winter 26apos 3Bs Day 54121 1Lumie Reveals Light Levels Received In July Are As Low As A Winter 26apos 3Bs Day 54121 2Lumie Reveals Light Levels Received In July Are As Low As A Winter 26apos 3Bs Day 54121 3Los Angeles Criminal Defense Attorneys Secure Insanity Verdicts in Two Southern California Murder Cases 54118 1Los Angeles Criminal Defense Attorneys Secure Insanity Verdicts in Two Southern California Murder Cases 54118 2HIV Treating Clinicians Support Health Care Reform Express Caution 54115 1HIV Treating Clinicians Support Health Care Reform Express Caution 54115 2HIV Treating Clinicians Support Health Care Reform Express Caution 54115 3HIV Treating Clinicians Support Health Care Reform Express Caution 54115 4HIV Treating Clinicians Support Health Care Reform Express Caution 54115 5
...g Data from Pivotal Trial Presented at American ...ng -, SAN FRANCISCO and CHICAGO, April 15 ,Mediva...lzheimer,s patients,taking the investigational dru...eir ability to perform daily tasks over a one-year...wed caregivers to save an average of nearly,one ho...
...flammatory Effects in the Tumor Microenvironment ...ficacy - - Studies Show Similar Results for a New... Antibody -, SAN DIEGO and TUSTIN, Calif.,...: PPHM ) today reported that,preclinical studies ...American Association for Cancer Research (AACR) co...
Other Medicine Technology:Medivation's Dimebon(TM) Significantly Improved Daily Function in Alzheimer's Disease Patients, Resulting in Reduced Need for Caregiver Assistance 2Medivation's Dimebon(TM) Significantly Improved Daily Function in Alzheimer's Disease Patients, Resulting in Reduced Need for Caregiver Assistance 3Medivation's Dimebon(TM) Significantly Improved Daily Function in Alzheimer's Disease Patients, Resulting in Reduced Need for Caregiver Assistance 4Medivation's Dimebon(TM) Significantly Improved Daily Function in Alzheimer's Disease Patients, Resulting in Reduced Need for Caregiver Assistance 5Peregrine Researchers Present New Preclinical Data at AACR Annual Meeting Confirming Unique Anti-Tumor Mechanism of Bavituximab 2Peregrine Researchers Present New Preclinical Data at AACR Annual Meeting Confirming Unique Anti-Tumor Mechanism of Bavituximab 3Peregrine Researchers Present New Preclinical Data at AACR Annual Meeting Confirming Unique Anti-Tumor Mechanism of Bavituximab 4
(Date:11/27/2009)...w-emission vehicles may reduce future disease burd...(HealthDay News) -- Encouraging city dwellers to w...much greater public health benefits than increased...ave found. , The study compared the projected h...ansport scenarios for London, England, and Delhi, ...
(Date:11/27/2009)...ulti-purpose bilingual coloring books designed for...siness community to educate - inform parents and c... issues to Dinosuars to ABC,S and a host of other ... (PRWEB) November 27, 2009 -- Today’s childr...p them busy any hour of the day, but one of the ol...
(Date:11/26/2009)...J., Nov. 27 The diabetes populatio... next 25 years and annual medical spending on the ...$113 billion today, according to a study published...tional Changing Diabetes ® Program (NCDP), a...s by a team from the University of Chicago. ,, ...
(Date:11/26/2009)...en on an emotional rollercoaster, study finds , ...ll it the fear factor meets the jubilant sports fa...pecially those who root for the winning team -- en...ntested match and victory was in doubt, producing ...hat this Thanksgiving weekend as you,re glued to t...
(Date:11/26/2009)...enton Communications announces a highly effective ...ilers struggling to make an economic recovery. , ...-- Flu fears is the type of challenge that could s...cording to Dr. David Benton, business growth exper... system – The Rfactor Intensive . “...
Breaking Medicine News(10 mins):Health News:More Foot Power, Less Car Pollution Best for Health 2Health News:Really Big Coloring Books Debuts Bi-Lingual Spanish-English Line of Custom and Imprintable Coloring Books 2Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 2Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 3Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 4Health News:Watching the Nail-Biting Big Game Hurts So Good 2Health News:Watching the Nail-Biting Big Game Hurts So Good 3Health News:Pharmacist Injects Cure for Ailing Businesses 2
...US bone graft substitute market to reach almost ...esearch Group, WALTHAM, Mass., May 14 With the a...ss, NuVasive has obtained the first,off-the-shelf ...l drive the BGS market to $1.9 billion in 2012,acc...
... PBTF Institute at Duke accelerates search for ...C., May 14 The Pediatric Brain,Tumor Foundation (...its,research institute at Duke University, bringin...use the funds to continue to sharpen its research ...
...s 2 to 3 times faster, dramatically boosting survi...) -- Researchers report they have dramatically inc...aused by bleeding within the brain by fine-tuning ...h rate in patients with this condition to an 80 pe...
...tensive people in morning use, researchers report ...A daily aspirin can control prehypertension, but o...ws. , An aspirin taken every morning didn,t lower ...sion annual meeting, in New Orleans. , A previous ...
...d primary teacher, hits five cities in one ... Joshua Rosenthal, founder and primary,teacher of ...,s largest,nutrition school, is hosting a public l...s and also discuss the,challenges and opportunitie...
...traZeneca (NYSE:,AZN) today announced that the U.S...SEROQUEL(R) (quetiapine fumarate tablets) for the ...isorder, as adjunct therapy to,lithium or divalpro...h depressive episodes in bipolar disorder and acut...
Other Medicine News:Health News:NuVasive Acquires First Stem Cell Bone Graft Substitute 2Health News:NuVasive Acquires First Stem Cell Bone Graft Substitute 3Health News:Video: Pediatric Brain Tumor Foundation Gives $6 Million Grant to Duke 2Health News:Clot-Busting Treatment Improves Bleeding Stroke Outcomes 2Health News:Aspirin at Bedtime Lowers Blood Pressure 2Health News:Institute for Integrative Nutrition Begins Road Tour 2Health News:FDA Approves AstraZeneca's Seroquel(R) for Maintenance Treatment in Bipolar Disorder 2Health News:FDA Approves AstraZeneca's Seroquel(R) for Maintenance Treatment in Bipolar Disorder 3Health News:FDA Approves AstraZeneca's Seroquel(R) for Maintenance Treatment in Bipolar Disorder 4Health News:FDA Approves AstraZeneca's Seroquel(R) for Maintenance Treatment in Bipolar Disorder 5Health News:FDA Approves AstraZeneca's Seroquel(R) for Maintenance Treatment in Bipolar Disorder 6Health News:FDA Approves AstraZeneca's Seroquel(R) for Maintenance Treatment in Bipolar Disorder 7Health News:FDA Approves AstraZeneca's Seroquel(R) for Maintenance Treatment in Bipolar Disorder 8Health News:FDA Approves AstraZeneca's Seroquel(R) for Maintenance Treatment in Bipolar Disorder 9
Atraumatic Grasping Forceps (Fallopian), dual-incision
Optima III 45 Noninsulated Strong Forceps, with ratchet
Snap-In Snap-Out®-II Angulated Dissecting Forceps
Snap-In Snap-Out®-II Micro Dolphin Dissecting Forceps Insert
Medicine Products: